RGS6 and metabolic dysfunction-associated steatotic liver disease: Another tumor suppressor, regulator of G protein signaling 6 (RGS6), is upregulated in the liver of NAFLD patients, forms a complex with ATM in the liver, promotes ATM phosphorylation, and drives hepatic steatosis (44, 45).